ClinicalTrials.govpublic full text
Open-label Study of CS-1008 for Subjects With Untreated and Unresectable Pancreatic Cancer
pancreatic cancer, chemotherapy naive, unresectable or metastatic pancreatic cancer, cs1008, gemcitabine, gemzar, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 828900
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.